The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia

NCT05919147 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Pioglitazone 45 mg
DRUG: Placebo

Sponsor

Pennington Biomedical Research Center